Thanks to your generosity, we are one step closer to providing personalized, precision cancer treatment to all our patients. We are grateful to the hundreds of donors who contributed to our World Cancer Day campaign, and to BMO for their transformative gift of $2 million to precision oncology research.

Precision oncology means providing the right treatment to the right patient at the right time. Using advanced tools and techniques, the MUHC’s oncologists can understand exactly what type of cancer a patient has and test treatment options in the laboratory. This helps ensure each patient receives the best treatment for their disease.

On World Cancer Day, February 4, 2022, you showed us the power of working together for a common cause, helping us raise $71,800 to support the outstanding work of the RI-MUHC’s cancer researchers. The MUHC Foundation is grateful to Ferron Campbell and the Campbell O’Connor Foundation for their generous matching gift of $20,000.

To everyone who donated, thank you for supporting our big dream to End Cancer as a deadly disease. Together, we nearly doubled our $40,000 goal.

BMO cheque presentation

Dr. Peter Metrakos

Image of doctor in a lab coat

Ferron Campbell, with Dr. Julia Burnier and MUHC Staff

Image of group posing for photo in a lab

Help Us End Cancer.

In 2018, 9.8 million people worldwide died from cancer, including 82,000 Canadians. 2 in 5 Canadians are expected to develop cancer, and one in four is expected to die from it. We have a plan to End Cancer: we will catch it early, understand it down to its genetics, discover its weaknesses, and keep it from taking lives.

Learn More